Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Irritable Bowel Syndrome is one of the most common gastrointestinal disorders, with a prevalence typically between 10% and 15% worldwide. Most people with Irritable Bowel Syndrome are under the age of 50, but many older people also suffer. Irritable Bowel Syndrome can affect many aspects of a patient's professional, emotional, and social life.
The North American Irritable Bowel Syndrome Treatment market is expected to dominate the global market throughout the forecast period. The global Irritable Bowel Syndrome Treatment market size is expected to reach USD 3.4 billion by 2026, exhibiting a 10.2% CAGR during the forecast period, 2020-2026.
Increased prevalence of target diseases and increased expansion of existing drugs may accelerate market growth. In addition, increased drug uptake and new product introductions are expected to drive the irritable bowel syndrome (IBS) therapeutic market.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Irritable Bowel Syndrome Treatment market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Irritable Bowel Syndrome Treatment market. Detailed analysis of key players, along with key growth strategies adopted by Irritable Bowel Syndrome Treatment industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
GlaxoSmithKline
Lexicon Pharmaceuticals
Abbott Laboratories
Valeant Pharmaceuticals International
Sucampo Pharmaceuticals
Allergan
Salix Pharmaceuticals
Ironwood Pharmaceuticals
By Type:
Irritable Bowel Syndrome with Constipation
Irritable Bowel Syndrome with Diarrhea
Irritable Bowel Syndrome with alternating Constipationand Diarrhea
By End-User:
Hospitals
Clinics
Homecare settings
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Irritable Bowel Syndrome Treatment Market
-
1.3 Market Segment by Type
-
1.3.1 USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Irritable Bowel Syndrome with Constipation from 2016 to 2027
-
1.3.2 USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Irritable Bowel Syndrome with Diarrhea from 2016 to 2027
-
1.3.3 USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Irritable Bowel Syndrome with alternating Constipationand Diarrhea from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Homecare settings from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Irritable Bowel Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Irritable Bowel Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Irritable Bowel Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Irritable Bowel Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Irritable Bowel Syndrome Treatment Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Irritable Bowel Syndrome Treatment by Major Types
-
3.4.1 Market Size and Growth Rate of Irritable Bowel Syndrome with Constipation
-
3.4.2 Market Size and Growth Rate of Irritable Bowel Syndrome with Diarrhea
-
3.4.3 Market Size and Growth Rate of Irritable Bowel Syndrome with alternating Constipationand Diarrhea
4 Segmentation of Irritable Bowel Syndrome Treatment Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Irritable Bowel Syndrome Treatment by Major End-Users
-
4.4.1 Market Size and Growth Rate of Irritable Bowel Syndrome Treatment in Hospitals
-
4.4.2 Market Size and Growth Rate of Irritable Bowel Syndrome Treatment in Clinics
-
4.4.3 Market Size and Growth Rate of Irritable Bowel Syndrome Treatment in Homecare settings
5 Market Analysis by Regions
-
5.1 USA Irritable Bowel Syndrome Treatment Production Analysis by Regions
-
5.2 USA Irritable Bowel Syndrome Treatment Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Irritable Bowel Syndrome Treatment Landscape Analysis
-
6.1 West USA Irritable Bowel Syndrome Treatment Landscape Analysis by Major Types
-
6.2 West USA Irritable Bowel Syndrome Treatment Landscape Analysis by Major End-Users
7 South USA Irritable Bowel Syndrome Treatment Landscape Analysis
-
7.1 South USA Irritable Bowel Syndrome Treatment Landscape Analysis by Major Types
-
7.2 South USA Irritable Bowel Syndrome Treatment Landscape Analysis by Major End-Users
8 Middle West USA Irritable Bowel Syndrome Treatment Landscape Analysis
-
8.1 Middle West USA Irritable Bowel Syndrome Treatment Landscape Analysis by Major Types
-
8.2 Middle West USA Irritable Bowel Syndrome Treatment Landscape Analysis by Major End-Users
9 Northeast USA Irritable Bowel Syndrome Treatment Landscape Analysis
-
9.1 Northeast USA Irritable Bowel Syndrome Treatment Landscape Analysis by Major Types
-
9.2 Northeast USA Irritable Bowel Syndrome Treatment Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 GlaxoSmithKline
-
10.1.1 GlaxoSmithKline Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Lexicon Pharmaceuticals
-
10.2.1 Lexicon Pharmaceuticals Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Abbott Laboratories
-
10.3.1 Abbott Laboratories Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Valeant Pharmaceuticals International
-
10.4.1 Valeant Pharmaceuticals International Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Sucampo Pharmaceuticals
-
10.5.1 Sucampo Pharmaceuticals Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Allergan
-
10.6.1 Allergan Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Salix Pharmaceuticals
-
10.7.1 Salix Pharmaceuticals Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Ironwood Pharmaceuticals
-
10.8.1 Ironwood Pharmaceuticals Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Irritable Bowel Syndrome with Constipation from 2016 to 2027
-
Figure USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Irritable Bowel Syndrome with Diarrhea from 2016 to 2027
-
Figure USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Irritable Bowel Syndrome with alternating Constipationand Diarrhea from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Irritable Bowel Syndrome Treatment Market Size and Growth Rate of Homecare settings from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Irritable Bowel Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Irritable Bowel Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Irritable Bowel Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Irritable Bowel Syndrome Treatment Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Irritable Bowel Syndrome Treatment Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Irritable Bowel Syndrome Treatment
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Irritable Bowel Syndrome Treatment by Different Types from 2016 to 2027
-
Table Consumption Share of Irritable Bowel Syndrome Treatment by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Irritable Bowel Syndrome with Constipation
-
Figure Market Size and Growth Rate of Irritable Bowel Syndrome with Diarrhea
-
Figure Market Size and Growth Rate of Irritable Bowel Syndrome with alternating Constipationand Diarrhea
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Irritable Bowel Syndrome Treatment by Different End-Users from 2016 to 2027
-
Table Consumption Share of Irritable Bowel Syndrome Treatment by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Homecare settings
-
Table USA Irritable Bowel Syndrome Treatment Production by Regions
-
Table USA Irritable Bowel Syndrome Treatment Production Share by Regions
-
Figure USA Irritable Bowel Syndrome Treatment Production Share by Regions in 2016
-
Figure USA Irritable Bowel Syndrome Treatment Production Share by Regions in 2021
-
Figure USA Irritable Bowel Syndrome Treatment Production Share by Regions in 2027
-
Table USA Irritable Bowel Syndrome Treatment Consumption by Regions
-
Table USA Irritable Bowel Syndrome Treatment Consumption Share by Regions
-
Figure USA Irritable Bowel Syndrome Treatment Consumption Share by Regions in 2016
-
Figure USA Irritable Bowel Syndrome Treatment Consumption Share by Regions in 2021
-
Figure USA Irritable Bowel Syndrome Treatment Consumption Share by Regions in 2027
-
Table West USA Irritable Bowel Syndrome Treatment Consumption by Types from 2016 to 2027
-
Table West USA Irritable Bowel Syndrome Treatment Consumption Share by Types from 2016 to 2027
-
Figure West USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2016
-
Figure West USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2021
-
Figure West USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2027
-
Table West USA Irritable Bowel Syndrome Treatment Consumption by End-Users from 2016 to 2027
-
Table West USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2016
-
Figure West USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2021
-
Figure West USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2027
-
Table South USA Irritable Bowel Syndrome Treatment Consumption by Types from 2016 to 2027
-
Table South USA Irritable Bowel Syndrome Treatment Consumption Share by Types from 2016 to 2027
-
Figure South USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2016
-
Figure South USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2021
-
Figure South USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2027
-
Table South USA Irritable Bowel Syndrome Treatment Consumption by End-Users from 2016 to 2027
-
Table South USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2016
-
Figure South USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2021
-
Figure South USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2027
-
Table Middle West USA Irritable Bowel Syndrome Treatment Consumption by Types from 2016 to 2027
-
Table Middle West USA Irritable Bowel Syndrome Treatment Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2016
-
Figure Middle West USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2021
-
Figure Middle West USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2027
-
Table Middle West USA Irritable Bowel Syndrome Treatment Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2016
-
Figure Middle West USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2021
-
Figure Middle West USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2027
-
Table Northeast USA Irritable Bowel Syndrome Treatment Consumption by Types from 2016 to 2027
-
Table Northeast USA Irritable Bowel Syndrome Treatment Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2016
-
Figure Northeast USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2021
-
Figure Northeast USA Irritable Bowel Syndrome Treatment Consumption Share by Types in 2027
-
Table Northeast USA Irritable Bowel Syndrome Treatment Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2016
-
Figure Northeast USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2021
-
Figure Northeast USA Irritable Bowel Syndrome Treatment Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Lexicon Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lexicon Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Lexicon Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Lexicon Pharmaceuticals
-
Table Product and Service Introduction of Lexicon Pharmaceuticals
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Valeant Pharmaceuticals International
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International
-
Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International
-
Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International
-
Table Product and Service Introduction of Valeant Pharmaceuticals International
-
Table Company Profile and Development Status of Sucampo Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sucampo Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Sucampo Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Sucampo Pharmaceuticals
-
Table Product and Service Introduction of Sucampo Pharmaceuticals
-
Table Company Profile and Development Status of Allergan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan
-
Figure Sales and Growth Rate Analysis of Allergan
-
Figure Revenue and Market Share Analysis of Allergan
-
Table Product and Service Introduction of Allergan
-
Table Company Profile and Development Status of Salix Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Salix Pharmaceuticals
-
Table Product and Service Introduction of Salix Pharmaceuticals
-
Table Company Profile and Development Status of Ironwood Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ironwood Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Ironwood Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Ironwood Pharmaceuticals
-
Table Product and Service Introduction of Ironwood Pharmaceuticals
-
